Literature DB >> 14145025

LUPUS ERYTHEMATOSUS.

R D PETERSON, R L VERNIER, R A GOOD.   

Abstract

Keywords:  ADOLESCENCE; ADRENAL CORTEX HORMONES; ANGIOGRAPHY; ANTICONVULSANTS; ANTIMALARIALS; ANTIMETABOLITES; BIOPSY; CHILD; CORTISONE; GENETICS, HUMAN; HYPERSENSITIVITY; INFANT; INFANT, NEWBORN; INFECTION; KIDNEY FUNCTION TESTS; LUPUS ERYTHEMATOSUS, DISCOID; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEPHRITIS; PATHOLOGY; RHEUMATOID FACTOR; SULFONAMIDES; SUNLIGHT; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1963        PMID： 14145025     DOI： 10.1016/s0031-3955(16)31476-6

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN： 0031-3955            Impact factor:   3.278


× No keyword cloud information.
  5 in total

1.  Corticosteroids. Pharmacology and uses in clinical paediatrics.

Authors:  K M Hemrajani; N K Khanna
Journal:  Indian J Pediatr       Date:  1974-10       Impact factor: 1.967

Review 2.  The treatment of lupus nephritis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

3.  Systemic lupus erythematosus in childhood.

Authors:  F Caeiro; F M Michielson; R Bernstein; G R Hughes; B M Ansell
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

4.  Congenital complete heart block in the newborn associated with maternal systemic lupus erythematosus and other connective tissue disorders.

Authors:  J D Hardy; S Solomon; G S Banwell; R Beach; V Wright; F M Howard
Journal:  Arch Dis Child       Date:  1979-01       Impact factor: 3.791

5.  Systemic lupus erythematosus with nephritis.

Authors:  M C Morris; J S Cameron; C Chantler; D R Turner
Journal:  Arch Dis Child       Date:  1981-10       Impact factor: 3.791
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.